Table of Contents
Scope and Themes
-
- What you need to know
- Definition
- Consumer research methodology
- Abbreviations and terms
- Abbreviations
- Terms
Executive Summary
-
- Sales driven by incidence, population factors
- A healthy market boosted by Rx switches and new product launches
- Tablets lead market as liquids slip and nasal products gain ground
- Mergers consolidate supply structure
- Ad & promo
- Professional staff drive sales to drug channel—even for common cold and allergy remedies
- The consumer
- Incidence of ailments and usage of remedies
- Attitudes towards CF&A remedies
- The ethnic consumer
- What the future holds
Market Drivers
-
- Incidence of cold, flu, and allergies
- Key points
- Details
-
- Figure 1: Severity of flu (only), October 2006
-
- Figure 2: Severity of nasal allergies/hay fever (only), October 2006
- Seasonal severity
-
- Figure 3: Influenza seasonal severity, in the U.S., 2000-06
- Higher contraction risk among children, women, elderly
-
- Figure 4: Population by age, 2002-12
-
- Figure 5: Population of OTC flu remedy users, based on those confirmed to have the flu, by gender, 2002-12
- Rx switches boost sales
- Uninsured turn to self-care, diagnosis
- Shift of pseudoephedrine to behind the counter
- Alternative remedies cut into OTC sales
- Vaccines and Rx remedies compete with OTC
-
- Figure 6: Preference for OTC vs. Rx cold, flu, and allergy remedies, October 2006
Market Size and Trends
-
- Market size
-
- Figure 7: Total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Wal-Mart estimate
- Market trends
- Multi-symptom relief
- Flavor
- Natural/organic ingredients
Market Segmentation
-
- Cold, flu, and allergy remedy segments
-
- Figure 8: FDM sales of cold, flu, and allergy remedies, segmented by delivery form, 2005 and 2007
- Tablets
-
- Figure 9: Sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2002-07
- Liquids
-
- Figure 10: Sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2002-07
- Nasal products
-
- Figure 11: Sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2002-07
Supply Structure
-
- Introduction
- Companies and brands
-
- Figure 12: Manufacturer FDM sales of cold, flu, and allergy remedies in the U.S., 2005 and 2007
- Tablets
-
- Figure 13: Manufacturer brand sales of cold, flu, and allergy remedy tablets, in the U.S., 2005 and 2007
- Liquids
-
- Figure 14: Manufacturer brand sales of cold, flu, and allergy remedy liquids, in the U.S., 2005 and 2007
- Nasal products
-
- Figure 15: Manufacturer brand sales of cold, flu, and allergy remedy nasal products, in the U.S., 2005 and 2007
Advertising and Promotion
-
- Introduction
-
- Figure 16: Promotional expenditures of the top CF&A manufacturers*, 2005-06
- Television marketing campaigns
- Schering-Plough
-
- Figure 17: Corocidin TV spot—high blood pressure-safe
- Pfizer, Inc.
-
- Figure 18: PediaCare liquid TV spot—pediatrician-endorsed
-
- Figure 19: Sudacare Shower Soother and Sudacare Vapor Plug TV spot—non-medicated
- Figure 20: Sudacare Shower Soother TV spot—non-medicated
- Procter & Gamble
-
- Figure 21: Vicks NyQuil and Vicks DayQuil TV spot—fast relief
-
- Figure 22: Vicks NyQuil TV spot—tried and true
- McNeil
-
- Figure 23: Children’s Motrin liquid TV spot—pediatrician-endorsed
-
- Figure 24: Tylenol Cold Multi-Symptom TV spot—multi-symptom; comparative advertising
-
- Figure 25: Children’s Tylenol Plus Cold TV spot—multi-symptom; doctor-recommended
- Adams Respiratory Therapeutics
-
- Figure 26: Mucinex DM TV spot—memorable character
- Wyeth Labs, Inc.
-
- Figure 27: Advil TV spot—multi-symptom relief
-
- Figure 28: Robitussin TV spot—wide product range
- Novartis
-
- Figure 29: TheraFlu Warming relief TV spot—restorative
-
- Figure 30: Triaminic Nighttime Cold & Cough TV spot—child-friendly advertising
- Other companies
-
- Figure 31: Zicam TV spot—consumer testimonial
-
- Figure 32: Zicam Cough Max TV spot—convenience
-
- Figure 33: Alka-Seltzer Plus liquid TV spot—multi-symptom relief
- Figure 34: Aleve cold/sinus TV spot—“real people;” circumvents pseudoephedrine restrictions
Retail Distribution
-
- Introduction
-
- Figure 35: U.S. FDM and convenience store retail sales of cold, flu, and allergy remedies, by channel, 2005 and 2007
- Drug stores
-
- Figure 36: U.S. drug store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Supermarkets
-
- Figure 37: U.S. supermarket sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Mass merchandisers
-
- Figure 38: U.S. mass merchandiser sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Convenience stores
-
- Figure 39: U.S. convenience store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
The Consumer: Use of Cold, Flu, and Allergy Remedies
-
- Summary
- Incidence of ailments, usage of remedies
- Incidence of flu and allergies
-
- Figure 40: Incidence of flu and nasal allergies/hay fever, by age, January-October 2006
- Severity of flu and nasal allergies/hay fever
-
- Figure 41: Severity of flu and nasal allergies/hay fever, by age, January-October 2006
- Use of cold, flu, and sinus remedies
-
- Figure 42: Use of cold, flu, and allergy remedies, by age, January-October 2006
- Preferred brands of cold, flu, and allergy remedies
-
- Figure 43: Preferred brands of cold, flu, and allergy remedies, by age, January-October 2006
- Frequency of usage of cold, flu, and allergy remedies
-
- Figure 44: Frequency of usage of cold, flu, and allergy remedies, by age, January-October 2006
- OTC vs. Rx cold, flu, and allergy remedies
-
- Figure 45: Preference for OTC vs. Rx cold, flu, and allergy remedies, by age, January-October 2006
- Ailments treated with cold, flu, and allergy remedies
-
- Figure 46: Ailments treated with cold, flu, and allergy remedies, by age, January-October 2006
- Household usage of children’s cold, flu, and allergy remedies
-
- Figure 47: Household usage of children’s cold, flu, and allergy remedies, January-October 2006
- Types and brands of children’s remedies preferred among households
-
- Figure 48: Household preference for types and brands of children’s cold, flu, and allergy remedies, January-October 2006
- Teen use of cold, flu, and allergy remedies
-
- Figure 49: Teen use of cold, flu, and allergy remedies, by gender and age, January-October 2006
The Consumer: Attitudes towards Cold, Flu, and Allergy Remedies and Their Side Effects
-
- Summary
- Attitudes towards cold, flu, and allergy remedies
-
- Figure 50: Attitudes towards cold, flu, and allergy remedies, by gender, August 2007
-
- Figure 51: Attitudes towards cold, flu, and allergy remedies, by age, August 2007
-
- Figure 52: Attitudes towards cold, flu, and allergy remedies, by number of children in household, August 2007
- Side effects from cold, flu, allergy remedies
-
- Figure 53: cold, flu, and allergy remedy side effects experienced in the past 12 months, by age, August 2007
The Consumer: Ethnic Use of Cold, Flu, and Allergy Remedies
-
- Summary
- Incidence of ailments, usage of remedies among ethnicities
- Incidence of flu and allergies among ethnicities
-
- Figure 54: Incidence of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006
- Severity of flu and nasal allergies/hay fever among ethnicities
-
- Figure 55: Severity of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006
- Preferred formulations of cold, flu, and allergy remedies among ethnicities
-
- Figure 56: Preference for 4-6-hour or 12-hour cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Preferred brands of cold, flu, and allergy remedies among ethnicities
-
- Figure 57: Preferred brands of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Frequency of usage of cold, flu, and allergy remedies among ethnicities
-
- Figure 58: Frequency of usage of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- OTC vs. Rx cold, flu, and allergy remedies preferences among ethnicities
-
- Figure 59: Preference for OTC vs. Rx cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Ailments ethnicities treat with cold, flu, and allergy remedies
-
- Figure 60: Ailments treated with cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Attitudes towards cold, flu, and allergy remedies among ethnicities
-
- Figure 61: Attitudes towards cold, flu, and allergy remedies, by race/ethnicity, August 2007
- Side effects from cold, flu, allergy remedies experienced among ethnicities
-
- Figure 62: cold, flu, and allergy remedy side effects experienced in the past 12 months, by race/ethnicity, August 2007
Future and Forecast
-
- Future trends
- OTC switch of Zyrtec promises market boost
- FDA advisory panel advises against children’s cough and cold remedies; manufacturers pull infants’ remedies
- Market forecast
- Cold, flu, and allergy remedies
-
- Figure 63: Forecast of total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2007-12
- Cold, flu, and allergy remedy tablets
-
- Figure 64: Forecast of U.S. FDM sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2007-12
- Cold, flu, and allergy remedy liquids
-
- Figure 65: Forecast of U.S. FDM sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2007-12
- Cold, flu, and allergy remedy nasal products
-
- Figure 66: Forecast of U.S. FDM sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2007-12
- Forecast factors
Appendix: Trade Associations
Back to top